BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21520163)

  • 1. Treatment decision-making for localized prostate cancer: what younger men choose and why.
    Sidana A; Hernandez DJ; Feng Z; Partin AW; Trock BJ; Saha S; Epstein JI
    Prostate; 2012 Jan; 72(1):58-64. PubMed ID: 21520163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
    Xu J; Janisse J; Goodman M
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
    Bayliss DR; Duff J; Stricker P; Walker K
    Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making processes among men with low-risk prostate cancer: A survey study.
    Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
    Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Affecting Satisfaction with the Decision-Making Process and Decision Regret for Men with a New Diagnosis of Prostate Cancer.
    Skyring TA; Mansfield KJ; Mullan JR
    Am J Mens Health; 2021; 15(4):15579883211026812. PubMed ID: 34261353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
    Hall JD; Boyd JC; Lippert MC; Theodorescu D
    Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
    Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
    Orom H; Homish DL; Homish GG; Underwood W
    Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
    Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
    BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options.
    Bayliss D; Duff J; Stricker P; Walker K
    Urol Nurs; 2016; 36(3):141-9. PubMed ID: 27501595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prostate cancer--which treatment do men prefer and why?
    Anandadas CN; Clarke NW; Davidson SE; O'Reilly PH; Logue JP; Gilmore L; Swindell R; Brough RJ; Wemyss-Holden GD; Lau MW; Javle PM; Ramani VA; Wylie JP; Collins GN; Brown S; Cowan RA;
    BJU Int; 2011 Jun; 107(11):1762-8. PubMed ID: 21083643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Decision Making in Prostate Cancer Care-Encouraging Every Patient to be Actively Involved in Decision Making or Ensuring the Patient Preferred Level of Involvement?
    van Stam MA; Pieterse AH; van der Poel HG; Bosch JLHR; Tillier C; Horenblas S; Aaronson NK
    J Urol; 2018 Sep; 200(3):582-589. PubMed ID: 29501555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.
    Kim SP; Knight SJ; Tomori C; Colella KM; Schoor RA; Shih L; Kuzel TM; Nadler RB; Bennett CL
    Cancer Invest; 2001; 19(7):684-91. PubMed ID: 11577809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
    Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
    Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic.
    Hurwitz LM; Cullen J; Elsamanoudi S; Kim DJ; Hudak J; Colston M; Travis J; Kuo HC; Porter CR; Rosner IL
    Urol Oncol; 2016 May; 34(5):233.e17-25. PubMed ID: 26705101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.